EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Branded Legacy's enterprise value is $0.02 Mil.
Branded Legacy's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.31 Mil. Therefore, Branded Legacy's EV-to-EBITDA for today is -0.07.
The historical rank and industry rank for Branded Legacy's EV-to-EBITDA or its related term are showing as below:
BLEGD's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.915 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Branded Legacy's PE Ratio (TTM) for today is calculated as:
Branded Legacy's share price for today is $0.0072.
Branded Legacy's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.021.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Branded Legacy's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLEGD vs UPDC, RIBT, GDMK: EV-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Branded Legacy's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Branded Legacy EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Branded Legacy's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Branded Legacy's EV-to-EBITDA falls into.
Branded Legacy's current Enterprise Value is $0.02 Mil.
Branded Legacy's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Branded Legacy (BLEGD) has a EV-to-EBITDA of -0.07 as of Jul. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Branded Legacy.
Is Branded Legacy's EV-to-EBITDA too high?
Branded Legacy's current EV-to-EBITDA is -0.07.
How does Branded Legacy's EV-to-EBITDA compare to UPDC and RIBT?
Branded Legacy's EV-to-EBITDA of -0.07 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBITDA is 12.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.92, based on 740 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Branded Legacy. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Branded Legacy's current EV-to-EBITDA is -0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEGD) has a current EV-to-EBITDA of -0.07. The current EV-to-EBITDA is -0.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Branded Legacy (BLEGD), the current EV-to-EBITDA is -0.07 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLEGD has been successfully added to your 